The purpose of this study is to compare pain level (according to numerical score)at 4, 8, 12 and 24 postoperative hours between patients under transverse abdominal plain blockade (TAP) and patients under conventional analgesia. Also the opioid consumption is assessed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
141
Bupivacaine 0.25%. Maximum 150 mg. A maximum of 75 mg bupivacaine is administered in each side (posterior and subcostal TAP) in a single puncture.
Fundació Puigvert
Barcelona, Barcelona, Spain
Pain level
Pain is assessed by numerical scale (0 to 10) where 0 is no pain and 10 is the most intense pain possible. Pain will be assessed at 4, 6 , 8, 12 and 24 hours.
Time frame: Change in pain from admittance to 24 hours postoperatively
Analgesic consumption as a rescue therapy
Analgesic consumption: morphine in miligrams.
Time frame: within 24 postoperative hours
Incidence of postoperative nausea and vomiting (PONV) related to therapy
Assessment of PONV incidence and antiemetic drugs consumption.
Time frame: within 24 postoperative hours
Incidence of urethral/bladder spasm
Pain due to bladder catheter.
Time frame: within 24 postoperative hours
Assessment of oral intake tolerance
Assessment at 6 postoperative hours for liquids, and solid food at 24 postoperative hours.
Time frame: within 24 postoperative hours
Patient satisfaction
Assessed by ordinal scale: Very pleased/Pleased/little pleased/little unpleased/unpleased/very unpleased
Time frame: within 24 postoperative hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.